Health
Medicine to prevent patients from developing COVID-19 tested in UK – TASS
Scientists hope that people wouls be protected from COVID-19 for a period of between six months and one year
LONDON, December 26. /TASS/. A medicine that can potentially prevent people exposed to novel coronavirus from developing COVID-19 is now being tested in the United Kingdom, the Guardian reported on its website Friday.
The medicine, based on monoclonal antibodies created in a laboratory, was developed by UK-Swedish pharmaceutical company AstraZeneca and the University College London Hospitals.
“If we can prove that this treatment works and prevent people who are exposed to the virus going on to develop…
-
Noosa News17 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General15 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News8 hours agoMurray Watt claims Queensland will follow Sussan Ley and ditch net zero by 2050
-
Noosa News18 hours agoBoy charged over E-Bike crash